about
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseLifetime prevalence of mood and anxiety disorders in fragile X premutation carriersTreatment of Depression in the Patient with Parkinson's Disease.Clinical correlates of depressive symptoms in familial Parkinson's disease.Parkinson's disease: the quintessential neuropsychiatric disorderLeg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial diseaseNeuroticism and extraversion in association with quality of life in patients with Parkinson's disease.Neuropsychology for movement disorders neurosurgery.Cognitive and affective correlates of temperament in Parkinson's diseaseRange of neuropsychiatric disturbances in patients with Parkinson's disease.Apathy in Parkinson's disease.Depression in Parkinson's disease: conceptual issues and clinical challenges.The impact of depressive symptoms in early Parkinson disease.Treatment of behavioural symptoms and dementia in Parkinson's disease.Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group.Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depressionPrevalence and associations for symptoms of depression in patients with Parkinson's disease: a Sri Lankan experience.CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approachAnxiety rating scales in Parkinson's disease: critique and recommendations.The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.Depression in Parkinson's disease. Pharmacological characteristics and treatment.Anxiety disorders in Parkinson's disease: prevalence and risk factors.The longitudinal impact of depression on disability in Parkinson disease.The impact of social networks on the relationship between functional impairment and depressive symptoms in older adults.Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease.Influence of polychlorinated biphenyls and turning preference on striatal dopamine metabolism.Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system.White matter microstructure changes in the thalamus in Parkinson disease with depression: A diffusion tensor MR imaging study.Major depressive disorder in Parkinson's disease: a register-based study.Mood disturbances and cognitive functioning in Parkinson's disease: the effects of disease duration and side of onset of motor symptoms.Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.Apathy and depression in Parkinson disease.The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease.Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
P2860
Q33647691-376C0580-0B76-4166-8E8A-35C56CA51B48Q33684243-9A9D83D5-A76B-400E-9AF9-4C657678C7F3Q33704127-1F913E77-92C5-4EAF-B45C-CB38DAFBD35DQ33861294-DF9A40A3-E2E0-4A93-B7A7-2EF78C453DD4Q33917094-2BFD5FD3-9BD6-4193-9A8F-0F60527BF7DAQ34749738-CFD05ADB-F4DC-4933-A08F-5CFE566BCE7DQ34874497-B37B51FE-ACB9-4C4F-B68E-79F868DA1C85Q35105765-D3F39E91-740A-4322-9E68-2F602AD633E7Q35173323-F36E5C1F-B244-4C55-9A2B-E5D790285512Q35453530-F13160DD-B2BB-4477-AE18-B62EE45A270DQ35560120-C76E7B8C-9057-403F-B1A0-2B1A8A5F221DQ35863400-E64FB701-453E-4756-B3DD-BB10AC609759Q36074454-1E58FBC5-7021-4483-BCEE-2CCBF496F932Q36089350-B7A9F5B4-8E4A-436E-A6AF-7AA199EBC555Q36279999-918523D8-A418-49C8-98D8-756C465E6E38Q36336894-6C5D45ED-54A6-4720-977B-A75E3BB0C669Q37010912-BE312808-2DEA-4AB1-88D4-811F55314039Q37035231-89AE3717-C158-46F1-AF2E-EAD42D6BAC7DQ37269003-F8747B36-A4A3-4ABD-907C-936A41CF424AQ37841542-45AFC9F6-B2CB-42B6-94FD-A5602F6C0DF0Q39450868-72D44AB4-8380-4D33-94EF-E1363FB806C6Q39874201-95E8718D-11C1-47FB-8D15-53F160E41037Q40630530-FDE0A6B5-34F7-4390-8B7D-68253D68A859Q40974723-424CE8E3-DBEC-4DB3-8A72-68E58EA12989Q42413314-2A223043-DDC3-4600-811A-838E72A3B76FQ46372028-F9FE8742-3A20-4CEC-BBBE-059668D018FDQ48080132-9520D971-4F39-4C4A-9EC7-C61F135DCA16Q48091560-D947B00B-5C25-4D0A-A940-DAAE0994025BQ48499341-E2E03F0C-2BF4-400F-8E8C-4D6673D70917Q48539794-BA30B122-CBA7-4145-9F59-ACAFB7DE8DA7Q48621833-30233538-8EE9-4B7A-A43C-2BF334C6E00EQ48895488-BB2EE429-41AE-4475-8270-EA4108A8293AQ48930449-6D0CA26D-B6A7-45B0-8423-2526454FF29BQ50858181-68BCB708-B5AA-4058-8407-689B2C34F981Q51505399-B6345565-F45E-45A2-A3D2-417FA8656255Q51758888-AF1578CD-A3AA-42F6-BD8A-74C83BD04DAAQ51941601-68A21FF7-8DC8-493C-941A-875C67C46D11
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Depression and disability in Parkinson's disease.
@en
Depression and disability in Parkinson's disease.
@nl
type
label
Depression and disability in Parkinson's disease.
@en
Depression and disability in Parkinson's disease.
@nl
prefLabel
Depression and disability in Parkinson's disease.
@en
Depression and disability in Parkinson's disease.
@nl
P2093
P356
P1476
Depression and disability in Parkinson's disease.
@en
P2093
P356
10.1176/JNP.8.1.20
P577
1996-01-01T00:00:00Z